IVP Limited
IVP Limited (IVP) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
ivpindia.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|
| Sales | 149 Cr | 138 Cr | 147 Cr | 145 Cr |
| Operating expenses (approx.) | 142 Cr | 134 Cr | 139 Cr | 136 Cr |
| EBITDA | 8 Cr | 4 Cr | 8 Cr | 9 Cr |
| OPM % | 5.2% | 3.1% | 5.5% | 6.0% |
| Other income | 0.94 Cr | 1 Cr | 0.89 Cr | 1 Cr |
| Interest | 2 Cr | 2 Cr | 2 Cr | 2 Cr |
| Depreciation | 1 Cr | 2 Cr | 2 Cr | 2 Cr |
| Profit before tax | 5 Cr | 2 Cr | 5 Cr | 6 Cr |
| Tax % | 25.6% | 30.0% | 24.5% | 25.1% |
| Net profit | 4 Cr | 1 Cr | 4 Cr | 5 Cr |
| EPS (₹) | ₹3.71 | ₹1.15 | ₹3.87 | ₹4.48 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 539 Cr | Sign in for TTM |
| Operating expenses (approx.) | 514 Cr | Sign in for TTM |
| EBITDA | 25 Cr | Sign in for TTM |
| OPM % | 4.7% | Sign in for TTM |
| Other income | 4 Cr | Sign in for TTM |
| Interest | 8 Cr | Sign in for TTM |
| Depreciation | 6 Cr | Sign in for TTM |
| Profit before tax | 15 Cr | Sign in for TTM |
| Tax % | 25.9% | Sign in for TTM |
| Net profit | 11 Cr | Sign in for TTM |
| EPS (₹) | ₹10.96 | Sign in for TTM |
| Dividend payout % | 9.1% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 |
|---|---|
| Equity capital | 10 Cr |
| Reserves | 129 Cr |
| Borrowings | 104 Cr |
| Other liabilities | 104 Cr |
| Total liabilities | 348 Cr |
| Fixed assets (net) | 70 Cr |
| CWIP | 0.18 Cr |
| Investments | 0.09 Cr |
| Loans & advances | 0.19 Cr |
| Inventories | 83 Cr |
| Trade receivables | 182 Cr |
| Cash & bank | 1 Cr |
| Other assets | 10 Cr |
| Total assets | 348 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 |
|---|---|
| Cash from operating activity | -2 Cr |
| Cash from investing | -5 Cr |
| Cash from financing | 6 Cr |
| Net cash flow | -0.90 Cr |
| Free cash flow (OCF − Capex) | -7 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 |
|---|---|
| ROCE % | 9.5% |
| ROE % | 8.1% |
| Debtor days | 123 |
| Inventory days | 70 |
| Days payable | 79 |
| Cash conversion cycle | 114 |
| Debt / equity | 0.75 |
| Current ratio | 1.32 |
| Net debt / EBITDA | 4.10 |
Compare with peers
Loading peers…